Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents

In the present study novel heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) (1, 2, 3, 4a-e and 5a-e) were designed and synthesized and investigated for their antimicrobial (against selected bacteria and fungi) and anticancer potential. The molecules 4e and 5e...

Full description

Saved in:
Bibliographic Details
Main Authors: Richie R Bhandare, Chandrashekar S.Munikrishnappa, G.V. Suresh Kumar, Sathish Kumar Konidala, Dilep Kumar Sigalapalli, Yogesh Vaishnav, Sampath Chinnam, Haya Yasin, Ahmed A. Al-karmalawy, Afzal B. Shaik
Format: Article
Language:English
Published: Springer 2022-05-01
Series:Journal of Saudi Chemical Society
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319610322000291
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849324705930018816
author Richie R Bhandare
Chandrashekar S.Munikrishnappa
G.V. Suresh Kumar
Sathish Kumar Konidala
Dilep Kumar Sigalapalli
Yogesh Vaishnav
Sampath Chinnam
Haya Yasin
Ahmed A. Al-karmalawy
Afzal B. Shaik
author_facet Richie R Bhandare
Chandrashekar S.Munikrishnappa
G.V. Suresh Kumar
Sathish Kumar Konidala
Dilep Kumar Sigalapalli
Yogesh Vaishnav
Sampath Chinnam
Haya Yasin
Ahmed A. Al-karmalawy
Afzal B. Shaik
author_sort Richie R Bhandare
collection DOAJ
description In the present study novel heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) (1, 2, 3, 4a-e and 5a-e) were designed and synthesized and investigated for their antimicrobial (against selected bacteria and fungi) and anticancer potential. The molecules 4e and 5e containing 4-fluoro phenyl and 4-fluoro benzyl substituents showed promising antimicrobial (antibacterial and antifungal activities with MICs ranging between 0.5 and 8 µg/mL. Compounds 3 exhibited potent anticancer activity with an IC50 value of 0.49 ± 1.45 µM against the human gastric cancer cell line (BGC-823) whereas compound 4e displayed an IC50 value of 0.65 ± 0.53 µM against breast cancer (MCF-7) cell line respectively. All compounds showed selective toxicity against the cancer cell lines compared to human normal liver cell lines. Molecular docking studies of the most potent compounds (3 and 4e) against selected microbial and cancer proteins revealed the crucial binding interactions of the potent compounds with the target enzymes. Compounds 3 and 4e are promising lead molecules to be developed as potential drug candidates.
format Article
id doaj-art-a8bf4feb331f4c21a4d584d26813158d
institution Kabale University
issn 1319-6103
language English
publishDate 2022-05-01
publisher Springer
record_format Article
series Journal of Saudi Chemical Society
spelling doaj-art-a8bf4feb331f4c21a4d584d26813158d2025-08-20T03:48:36ZengSpringerJournal of Saudi Chemical Society1319-61032022-05-0126310144710.1016/j.jscs.2022.101447Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agentsRichie R Bhandare0Chandrashekar S.Munikrishnappa1G.V. Suresh Kumar2Sathish Kumar Konidala3Dilep Kumar Sigalapalli4Yogesh Vaishnav5Sampath Chinnam6Haya Yasin7Ahmed A. Al-karmalawy8Afzal B. Shaik9Department of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, Ajman University, Ajman, PO Box 346, United Arab Emirates; Center of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates; Corresponding authors.Rallis India Limited, A TATA Enterprise, # 73/1, 1C, 1D, Byregowda Industrial Layout, Srigandhanagara, Hegganahalli, Peenya, Bangalore 560091, Karnataka, IndiaEast West College of Pharmacy, #63, I Phase, BEL Layout, Bharathnagar, Vishwaneedam PO, Bangalore 560091, Karnataka, IndiaDepartment of Pharmaceutical Sciences, Vignan's Foundation for Science, Technology and Research, Guntur, Andhra Pradesh, IndiaDepartment of Pharmaceutical Chemistry, Vignan Pharmacy College, Jawaharlal Nehru Technological University, Vadlamudi 522213, Andhra Pradesh, IndiaFaculty of Pharmaceutical Sciences, Shri Shankaracharya Technical Campus, Junwani, Bhilai 491001, Chhattisgarh, IndiaDepartment of Chemistry, M.S. Ramaiah Institute of Technology (Affiliated to Visvesvaraya Technological University, Belgaum), Bengaluru, Karnataka, IndiaDepartment of Pharmaceutical Sciences, College of Pharmacy & Health Sciences, Ajman University, Ajman, PO Box 346, United Arab EmiratesDepartment of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, EgyptDepartment of Pharmaceutical Chemistry, Vignan Pharmacy College, Jawaharlal Nehru Technological University, Vadlamudi 522213, Andhra Pradesh, India; Corresponding authors.In the present study novel heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) (1, 2, 3, 4a-e and 5a-e) were designed and synthesized and investigated for their antimicrobial (against selected bacteria and fungi) and anticancer potential. The molecules 4e and 5e containing 4-fluoro phenyl and 4-fluoro benzyl substituents showed promising antimicrobial (antibacterial and antifungal activities with MICs ranging between 0.5 and 8 µg/mL. Compounds 3 exhibited potent anticancer activity with an IC50 value of 0.49 ± 1.45 µM against the human gastric cancer cell line (BGC-823) whereas compound 4e displayed an IC50 value of 0.65 ± 0.53 µM against breast cancer (MCF-7) cell line respectively. All compounds showed selective toxicity against the cancer cell lines compared to human normal liver cell lines. Molecular docking studies of the most potent compounds (3 and 4e) against selected microbial and cancer proteins revealed the crucial binding interactions of the potent compounds with the target enzymes. Compounds 3 and 4e are promising lead molecules to be developed as potential drug candidates.http://www.sciencedirect.com/science/article/pii/S1319610322000291Heterocyclic tetradsCancerMicrobial infectionsDocking
spellingShingle Richie R Bhandare
Chandrashekar S.Munikrishnappa
G.V. Suresh Kumar
Sathish Kumar Konidala
Dilep Kumar Sigalapalli
Yogesh Vaishnav
Sampath Chinnam
Haya Yasin
Ahmed A. Al-karmalawy
Afzal B. Shaik
Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents
Journal of Saudi Chemical Society
Heterocyclic tetrads
Cancer
Microbial infections
Docking
title Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents
title_full Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents
title_fullStr Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents
title_full_unstemmed Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents
title_short Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents
title_sort multistep synthesis and screening of heterocyclic tetrads containing furan pyrazoline thiazole and triazole or oxadiazole as antimicrobial and anticancer agents
topic Heterocyclic tetrads
Cancer
Microbial infections
Docking
url http://www.sciencedirect.com/science/article/pii/S1319610322000291
work_keys_str_mv AT richierbhandare multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT chandrashekarsmunikrishnappa multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT gvsureshkumar multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT sathishkumarkonidala multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT dilepkumarsigalapalli multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT yogeshvaishnav multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT sampathchinnam multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT hayayasin multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT ahmedaalkarmalawy multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents
AT afzalbshaik multistepsynthesisandscreeningofheterocyclictetradscontainingfuranpyrazolinethiazoleandtriazoleoroxadiazoleasantimicrobialandanticanceragents